Production (Stage)
Stemtech Corporation
STEK
$0.0244
-$0.0002-0.81%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.69% | 9.97% | 22.34% | 13.98% | 7.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.69% | 9.97% | 22.34% | 13.98% | 7.94% |
| Cost of Revenue | 32.43% | 15.14% | 18.92% | -3.84% | -13.95% |
| Gross Profit | -4.91% | 8.34% | 23.35% | 20.01% | 15.45% |
| SG&A Expenses | -24.81% | 13.71% | -16.14% | -14.97% | -3.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.65% | 13.71% | -12.90% | -13.88% | -4.56% |
| Operating Income | 43.51% | -19.10% | 38.52% | 34.62% | 15.90% |
| Income Before Tax | 30.55% | -30.54% | -135.30% | 55.53% | 36.37% |
| Income Tax Expenses | -- | -- | -46.05% | -41.20% | -100.00% |
| Earnings from Continuing Operations | 30.55% | -27.51% | -135.68% | 55.45% | 37.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 82.35% | -90.94% | -100.52% | -94.83% | -98.07% |
| Net Income | 30.58% | -28.24% | -135.54% | 55.17% | 36.45% |
| EBIT | 43.51% | -19.10% | 38.52% | 34.62% | 15.90% |
| EBITDA | 43.85% | -173.62% | 20.54% | 19.50% | -16.62% |
| EPS Basic | 47.70% | 18.24% | -115.70% | 78.58% | 64.80% |
| Normalized Basic EPS | 61.23% | 38.32% | -126.01% | 78.91% | 65.30% |
| EPS Diluted | 40.93% | 10.96% | -118.44% | 77.35% | 64.35% |
| Normalized Diluted EPS | 61.23% | 38.32% | -126.01% | 78.91% | 65.30% |
| Average Basic Shares Outstanding | 26.94% | 42.12% | 65.87% | 92.72% | 93.31% |
| Average Diluted Shares Outstanding | 26.94% | 42.12% | 65.87% | 92.72% | 93.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |